Table 2.
Donor number | Patient number | ||||||||||
Healthy donor PBMC | I | II | III | IV | |||||||
Unstimulated | 0 | 0 | 0 | 0 | |||||||
Stimulated | 2.7 | 2.7 | 1.4 | 1.8 | |||||||
Samples of VSCC | 12 | 13 | 15 | 30 | 34 | 38 | 53 | ||||
Tumour | 850 | 4890 | 19000 | 1850 | 6000 | 481 | 1600 | ||||
Adjacent uninvolved tissue | 2920 | 290 | 2000 | 946 | 1650 | 194 | 818 | ||||
Metastatic lymph node | x | x | 35300 | 810 | 3600 | 609 | 579 | ||||
Uninvolved lymph node | 0.3a | 0a | 24 | 600 | 274 | 2.5 | 0 | ||||
740 | 0.7 | ||||||||||
0 | |||||||||||
Serum | n.d | 0.9 | n.d. | n.d. | 5.6 | 1.8 | 2 |
Concentrations of SCCA in the cells and post-surgical samples are presented in nanogram per milligram of cell protein and in the sera in nanogram per millilitre of serum
x no metastatic nodes found, n.d. not determined
aMore than one lymph node of this patient was tested